These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


395 related items for PubMed ID: 25435430

  • 1. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.
    Chatterjee A, Chattopadhyay D, Chakrabarti G.
    Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430
    [Abstract] [Full Text] [Related]

  • 2. miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression.
    Chatterjee A, Chattopadhyay D, Chakrabarti G.
    PLoS One; 2014 Feb; 9(4):e95716. PubMed ID: 24755562
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.
    Xu X, Jin S, Ma Y, Fan Z, Yan Z, Li W, Song Q, You W, Lyu Z, Song Y, Shi P, Liu Y, Han X, Li L, Li Y, Liu Y, Ye Q.
    J Mol Med (Berl); 2017 Aug; 95(8):861-871. PubMed ID: 28487996
    [Abstract] [Full Text] [Related]

  • 11. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Wesarg E, Hoffarth S, Wiewrodt R, Kröll M, Biesterfeld S, Huber C, Schuler M.
    Int J Cancer; 2007 Dec 01; 121(11):2387-94. PubMed ID: 17688235
    [Abstract] [Full Text] [Related]

  • 12. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
    Ye J, Zhang Z, Sun L, Fang Y, Xu X, Zhou G.
    Mol Biosyst; 2016 Oct 18; 12(11):3417-3424. PubMed ID: 27714074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Jeong JY, Kang H, Kim TH, Kim G, Heo JH, Kwon AY, Kim S, Jung SG, An HJ.
    Cancer Lett; 2017 Feb 01; 386():168-178. PubMed ID: 27887917
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
    Liu Y, Liu JH, Chai K, Tashiro S, Onodera S, Ikejima T.
    J Pharm Pharmacol; 2013 Nov 01; 65(11):1622-42. PubMed ID: 24102522
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Total Tanshinones-Induced Apoptosis and Autophagy Via Reactive Oxygen Species in Lung Cancer 95D Cells.
    Gao H, Sun W, Zhao W, Hao W, Leung CH, Lu J, Chen X.
    Am J Chin Med; 2015 Nov 01; 43(6):1265-79. PubMed ID: 26394653
    [Abstract] [Full Text] [Related]

  • 20. Andrographolide sodium bisulfate-induced apoptosis and autophagy in human proximal tubular endothelial cells is a ROS-mediated pathway.
    Lu H, Zhang XY, Wang YQ, Zheng XL, Yin-Zhao, Xing WM, Zhang Q.
    Environ Toxicol Pharmacol; 2014 Mar 01; 37(2):718-28. PubMed ID: 24607686
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.